Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Craig Brooks-Rooney"'
Autor:
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 6, Pp 1014-1023 (2019)
Background/Purpose: While direct-acting antiviral regimens have been approved for chronic hepatitis C (CHC) patients in Taiwan, reimbursement is limited to certain populations. Thus, pegylated interferon plus ribavirin (PEG-IFN/RBV) remains the stand
Externí odkaz:
https://doaj.org/article/daef8329372b4c10aaf0cc4a4b621cef
Autor:
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W. Ray Kim, Leland J. Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Wook Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Jung Woo Shin, Yao-Hsu Yang, Young-Suk Lim
Publikováno v:
Journal of hepatology.
Comparative risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) versus entecavir (ETV) remains controversial. This individual patient data (IPD) meta-analysis aimed to compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce4ac1efa5b8fbe1a853e61a64f53c2
https://pubmed.ncbi.nlm.nih.gov/36572349
https://pubmed.ncbi.nlm.nih.gov/36572349
Autor:
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Wong, W.Ra Kim, Leland Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Wook Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Jungwoo Shin, Yao-Hsu Yang, Young-Suk Lim
Publikováno v:
Journal of Hepatology. 77:S870-S871
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d61d5e42f7941973458010ddea552877
https://doi.org/10.1016/s0168-8278(22)02035-9
https://doi.org/10.1016/s0168-8278(22)02035-9
Autor:
Jia-Horng Kao, Tsai Yuan Hsieh, Ming-Lung Yu, Ching Chu Lo, Cheng Yuan Peng, Craig Brooks-Rooney, Wei Wen Su, Jyh Jou Chen, Chen-Hua Liu, Pin-Nan Cheng, Chi Yi Chen, Yi Hsiang Huang, Qian Ma, Chih-Lin Lin
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 6, Pp 1014-1023 (2019)
Background/Purpose: While direct-acting antiviral regimens have been approved for chronic hepatitis C (CHC) patients in Taiwan, reimbursement is limited to certain populations. Thus, pegylated interferon plus ribavirin (PEG-IFN/RBV) remains the stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b33bea90275a19d09299485e583066f
https://doi.org/10.1016/j.jfma.2018.10.020
https://doi.org/10.1016/j.jfma.2018.10.020
Autor:
Craig Brooks-Rooney, Hiroshi Yatsuhashi, Masayuki Kurosaki, Alvin Ng, Mindie H. Nguyen, I-Heng Lee, Hiroshi Yotsuyanagi
Publikováno v:
Digestive diseases (Basel, Switzerland). 40(1)
Introduction: Advancing age, comorbidity, and financial burden have been observed in chronic hepatitis B (CHB) patients globally. As Japan is leading the world in aging demographics, similar real-world data are urgently needed for its CHB population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1858004c27ea972e500f508d2ea3e62
https://pubmed.ncbi.nlm.nih.gov/33721872
https://pubmed.ncbi.nlm.nih.gov/33721872
Autor:
Ching Chu Lo, Ming-Lung Yu, Pin-Nan Cheng, Craig Brooks-Rooney, Yi Hsiang Huang, Cheng Yuan Peng, Chen-Hua Liu, Jyh Jou Chen, Tsai Yuan Hsieh, Wei Wen Su, Chi Yi Chen, Jia-Horng Kao, Chih-Lin Lin, Qian Ma
Publikováno v:
Alimentary Pharmacology & Therapeutics. 48:1290-1300
Background While direct-acting antivirals have been approved for treating hepatitis C, the guidelines highlight the importance of considering potential drug-drug interactions between DAAs and concomitant medications. Aim To assess comorbidity prevale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d133d426ca8ba80e13c0bd261f2c7d70
https://doi.org/10.1111/apt.15011
https://doi.org/10.1111/apt.15011
Autor:
Zobair M. Younossi, Francesco Negro, Atsushi Tanaka, Craig Brooks-Rooney, Yuichiro Eguchi, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, Mario U. Mondelli, Young-Suk Lim
Publikováno v:
Liver International, Vol. 37, No 2 (2017) pp. 159-172
Between 80 and 115 million people worldwide are chronically infected with hepatitis C virus, with 60%-90% of these being undiagnosed. Untreated chronic hepatitis C (CHC) is associated with progressive liver disease, cirrhosis, hepatocellular carcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2488c62aa1d22c0499b3bef5f890e599
https://doi.org/10.1111/liv.13272
https://doi.org/10.1111/liv.13272